Literature DB >> 15485416

Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study.

Coen D A Stehouwer1, Ronald M A Henry, Jacqueline M Dekker, Giel Nijpels, Robert J Heine, Lex M Bouter.   

Abstract

BACKGROUND: Extensive endothelial dysfunction (i.e., affecting many aspects of endothelial function) has been hypothesized to explain why microalbuminuria (MA) is associated with cardiovascular disease risk. However, it is not clear whether MA is specifically associated with impaired endothelial nitric oxide (NO) synthesis in individuals without and with type 2 diabetes.
METHODS: We did a population-based study in 645 individuals (mean age 68 years; 248 with normal glucose metabolism, 137 with impaired glucose metabolism, and 260 with type 2 diabetes) and investigated associations of MA [present (urinary albumin-creatinine ratio > or = 2 mg/mmol) versus absent, and in four categories (< 2, > or = 2 to 5, > or = 5 to 10, > or = 10 mg/mmol)] with ultrasonically measured brachial artery endothelium-dependent, flow-mediated (FMD; an estimate of endothelial NO synthesis) and endothelium-independent, nitroglycerin-induced vasodilation (NID).
RESULTS: FMD was 0.12 mm in the presence of MA (N=93; 49 with diabetes), and 0.18 in its absence (P=0.002). After adjustment for age, sex, baseline arterial diameter, and other potential confounders, FMD was 0.038 mm (95% CI, 0.001 to 0.075) lower in the presence of MA (P=0.04), and decreased linearly across MA categories [by 0.027 mm (0.007 to 0.046) per category increase of MA; P=0.007]. NID was similar in individuals with and without MA. Results were similar in individuals without and with diabetes.
CONCLUSION: Microalbuminuria is linearly associated with impaired endothelium-dependent, flow-mediated vasodilation in elderly individuals without and with diabetes. These findings support the concept that impaired endothelial nitric oxide synthesis plays a role in the association of microalbuminuria with cardiovascular disease risk.

Entities:  

Mesh:

Year:  2004        PMID: 15485416     DOI: 10.1111/j.1523-1755.2004.09211.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  56 in total

1.  Proteinuria and endothelial dysfunction in stable HIV-infected patients. A pilot study.

Authors:  Samir K Gupta; Kieren J Mather; Rajiv Agarwal; Chandan K Saha; Robert V Considine; Michael P Dubé
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

2.  Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh.

Authors:  Yu Chen; Faruque Parvez; Mary Gamble; Tariqul Islam; Alauddin Ahmed; Maria Argos; Joseph H Graziano; Habibul Ahsan
Journal:  Toxicol Appl Pharmacol       Date:  2009-01-27       Impact factor: 4.219

3.  Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.

Authors:  João Pedro Ferreira; Mário Santos; Sofia Almeida; Irene Marques; Paulo Bettencourt; Henrique Carvalho
Journal:  Clin Res Cardiol       Date:  2013-07-10       Impact factor: 5.460

4.  Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.

Authors:  Paul E Drawz; Arnold B Alper; Amanda H Anderson; Carolyn S Brecklin; Jeanne Charleston; Jing Chen; Rajat Deo; Michael J Fischer; Jiang He; Chi-Yuan Hsu; Yonghong Huan; Martin G Keane; John W Kusek; Gail K Makos; Edgar R Miller; Elsayed Z Soliman; Susan P Steigerwalt; Jonathan J Taliercio; Raymond R Townsend; Matthew R Weir; Jackson T Wright; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 8.237

5.  Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States.

Authors:  Manjula Kurella Tamura; Paul Muntner; Virginia Wadley; Mary Cushman; Neil A Zakai; Brian D Bradbury; Brett Kissela; Fred Unverzagt; George Howard; David Warnock; William McClellan
Journal:  Am J Kidney Dis       Date:  2011-08-04       Impact factor: 8.860

Review 6.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

7.  Capillary Rarefaction Associates with Albuminuria: The Maastricht Study.

Authors:  Remy J H Martens; Ronald M A Henry; Alfons J H M Houben; Carla J H van der Kallen; Abraham A Kroon; Casper G Schalkwijk; Miranda T Schram; Simone J S Sep; Nicolaas C Schaper; Pieter C Dagnelie; Dennis M J Muris; Ed H B M Gronenschild; Frank M van der Sande; Karel M L Leunissen; Jeroen P Kooman; Coen D A Stehouwer
Journal:  J Am Soc Nephrol       Date:  2016-05-09       Impact factor: 10.121

8.  Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Kristal J Aaron; Ruth C Campbell; Suzanne E Judd; Paul W Sanders; Paul Muntner
Journal:  Am J Clin Nutr       Date:  2011-08-31       Impact factor: 7.045

9.  High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function.

Authors:  Aiko Okubo; Ayumu Nakashima; Shigehiro Doi; Toshiki Doi; Toshinori Ueno; Kazuya Maeda; Ryo Tamura; Kiminori Yamane; Takao Masaki
Journal:  Clin Exp Nephrol       Date:  2020-02-19       Impact factor: 2.801

10.  Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy.

Authors:  Paolo Tessari; Diego Cecchet; Alessandra Cosma; Monica Vettore; Anna Coracina; Renato Millioni; Elisabetta Iori; Lucia Puricelli; Angelo Avogaro; Monica Vedovato
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.